Shanghai Bao Pharmaceuticals Co., Ltd.

HK$8.78As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2659Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (31.30%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$2.838B
ROIC (13.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.03
2.82%
569.00%
Hold 8|6|2|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.18
0.17
7.58%
18.49%
25.32%
17.30%
Revenue¥M
287.4
297.0
311.1
326.7
10.09%
8.14%
13.35%
12.58%
Peers (US$362.1M)
Cap (US$)
PE
356.5M
14.33x
Capital
TTM
5Y
10Y
Leveragex
1.893
(0.073)
(0.084)
EBIT/Intx
0.837
0.110
0.108
Own earn%
(112.46)
269.91
212.37
Sh yield%
35.80
12.00
13.06
Owners
Insiders/Inst%
11.16
40.55
Short interest%
1.53
SBC / revenue%
3.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
7